Skip to main content


Coronary CTO Re-Entry System


(Facilitated Antegrade Steering Technique in Chronic Total Occlusions)

Study Objective

To demonstrate the satety and efficacy of the CrossBoss and Stingray Coronary CTO Crossing and Re-Entry devices to recanalize coronary CTOs in comparison to historical controls.

  • Multi-center, non-randomized US IDE study
  • 147 patients in 16 centers

Safe and Effective

Use of the CrossBoss and Stingray Crossing and Re-Entry devices result in a high technical success, 77%, without increasing complications.1

Reduced Procedure Time

Procedural success was improved with a 28.1% reduction in mean procedure time (minutes) as well as a reduction in fluoroscopy time.1

Primary Endpoints
FAST-CTOs Primary Endpoint Data
Secondary Endpoint
FAST CTO - Secondary Endpoint Data

Principal Investigators

Patrick Whitlow MD, William Lombardi MD, Michael Wyman MD, Craig Thompson MD

Cleveland Clinic, PeaceHealth Medical Center/St Joseph Hospital, Torrance Memorial Medical Center, Yale University School of Medicine

1. Whitlow P. Lombardi W, Wyman M et al. Use of Novel Crossing and Re-Entry System in Coronary Chronic Total Occlusion That Have Failed Standard Crossing Techniques. Journal of American College of Cardiology Intervention. 2012;5:393-401.

2. Wyman M. The BridgePoint Medical CTO System: Results of the "Fast-CTO" US IDE Study. TCT 2010.